182 related articles for article (PubMed ID: 8207213)
1. Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B.
Johns LD; Sarr T; Ranges GE
J Immunol; 1994 Jun; 152(12):5877-82. PubMed ID: 8207213
[TBL] [Abstract][Full Text] [Related]
2. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
3. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
[TBL] [Abstract][Full Text] [Related]
4. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation.
Higuchi M; Singh S; Jaffrezou JP; Aggarwal BB
J Immunol; 1996 Jul; 157(1):297-304. PubMed ID: 8683130
[TBL] [Abstract][Full Text] [Related]
5. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.
Gerritsen ME; Shen CP; Perry CA
Am J Pathol; 1998 Feb; 152(2):505-12. PubMed ID: 9466577
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
Goto M; Yamada K; Katayama K; Tanaka I
Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
[TBL] [Abstract][Full Text] [Related]
7. Regulation of NF-kappa B activity in murine macrophages: effect of bacterial lipopolysaccharide and phorbol ester.
Vincenti MP; Burrell TA; Taffet SM
J Cell Physiol; 1992 Jan; 150(1):204-13. PubMed ID: 1730783
[TBL] [Abstract][Full Text] [Related]
8. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M
Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
[TBL] [Abstract][Full Text] [Related]
9. Microbial superantigens induce NF-kappa B in the human monocytic cell line THP-1.
Trede NS; Castigli E; Geha RS; Chatila T
J Immunol; 1993 Jun; 150(12):5604-13. PubMed ID: 8515079
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphatase-dependent/tyrosine kinase-independent induction of nuclear factor-kappa B by tumor necrosis factor-alpha: effects on prostaglandin endoperoxide synthase-2 mRNA accumulation.
Mahboubi K; Young W; Ferreri NR
J Pharmacol Exp Ther; 1998 May; 285(2):862-8. PubMed ID: 9580637
[TBL] [Abstract][Full Text] [Related]
13. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells.
Matsukura S; Stellato C; Plitt JR; Bickel C; Miura K; Georas SN; Casolaro V; Schleimer RP
J Immunol; 1999 Dec; 163(12):6876-83. PubMed ID: 10586089
[TBL] [Abstract][Full Text] [Related]
14. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
[TBL] [Abstract][Full Text] [Related]
15. TNF receptor-associated factor-2 is involved in both IL-1 beta and TNF-alpha signaling cascades leading to NF-kappa B activation and IL-8 expression in human intestinal epithelial cells.
Jobin C; Holt L; Bradham CA; Streetz K; Brenner DA; Sartor RB
J Immunol; 1999 Apr; 162(8):4447-54. PubMed ID: 10201981
[TBL] [Abstract][Full Text] [Related]
16. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways.
Min W; Pober JS
J Immunol; 1997 Oct; 159(7):3508-18. PubMed ID: 9317150
[TBL] [Abstract][Full Text] [Related]
17. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2873-80. PubMed ID: 9743348
[TBL] [Abstract][Full Text] [Related]
18. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
20. Effect of tumor necrosis factors, interferons, interleukins, and growth factors on the activation of NF-kappa B: evidence for lack of correlation with cell proliferation.
Chaturvedi MM; Higuchi M; Aggarwal BB
Lymphokine Cytokine Res; 1994 Oct; 13(5):309-13. PubMed ID: 7532017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
